Polynucleotides as a novel therapeutic approach in androgenetic alopecia: an analysis of effectiveness and safety
Archives of Dermatological Research · 14.02.2025 · 317 (1)
DOI: 10.1007/s00403-025-03908-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 14.02.2025. Verfasst von Wilai Thanasarnaksorn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Klong Luang, Pathum Thani, 12120, Thaila…. Hauptthemen laut MEDLINE: Alopecia, Hair. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Thailand Science Research and Innovation Fundamental Fund.
Abstract (Originalsprache)
Androgenetic alopecia (AGA) is a highly prevalent condition that poses a significant challenge to quality of life, yet the US Food and Drug Administration-approved treatments remain limited. Polynucleotides (PN) stimulate tissue regeneration by reducing inflammation, activation of growth factors and accelerating angiogenesis, which are vital for hair regrowth. This study aimed to assess the efficacy of PN in promoting hair regrowth by measuring changes in hair diameter and density in patients with AGA. This prospective study evaluated 28 patients with AGA who received four injection of DOT™ PN (DNA Fragment Optimizing Technology Polynucleotides) at four-week intervals. Hair diameter and density were quantitatively assessed using dermoscopic analysis. Treatment efficacy was also evaluated using patient and dermatologist satisfaction survey. Both hair diameter and density showed significant improvement, with hair diameter increased notably one month post-treatment and continuing to rise throughout the study. Total hair density improvements were evident from one months post-treatment onwards. Additionally, the dermatologist's assessment indicated stabilization in 60.7% of cases, while the patient assessment score indicated improvement in 82.1% of cases, with no serious side effects. This study demonstrates that PN effectively promotes hair regrowth in AGA patients. This is likely due to increased angiogenesis and anti-apoptotic effects. PN offers a promising new alternative for patients who have not responded to traditional treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Klong Luang, Pathum Thani, 12120, Thailand.
- Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Klong Luang, Pathum Thani, 12120, Thailand. kae_mdcu@yahoo.com.
Förderung
- Thailand Science Research and Innovation Fundamental Fund
Zitieren
APA
Thanasarnaksorn, W., Limsuchaiwat, N., Sirithanabadeekul, P., Charoensuksira, S., Suwanchinda, A., & Meephansan, J. (2025). Polynucleotides as a novel therapeutic approach in androgenetic alopecia: an analysis of effectiveness and safety. Archives of Dermatological Research, 317(1). https://doi.org/10.1007/s00403-025-03908-6
Vancouver
Thanasarnaksorn W, Limsuchaiwat N, Sirithanabadeekul P, Charoensuksira S, Suwanchinda A, Meephansan J. Polynucleotides as a novel therapeutic approach in androgenetic alopecia: an analysis of effectiveness and safety. Archives of Dermatological Research. 2025;317(1). doi:10.1007/s00403-025-03908-6
BibTeX
@article{Thanasarnaksorn2025,
author = {Thanasarnaksorn, Wilai and Limsuchaiwat, Nathamon and Sirithanabadeekul, Punyaphat and Charoensuksira, Sasin and Suwanchinda, Atchima and Meephansan, Jitlada},
title = {Polynucleotides as a novel therapeutic approach in androgenetic alopecia: an analysis of effectiveness and safety},
journal = {Archives of Dermatological Research},
year = {2025},
volume = {317},
number = {1},
doi = {10.1007/s00403-025-03908-6}
}
EUVIMED